Evaluación del sistema de información de medición de resultados informados por el paciente (PROMIS)-29 v2.1 para mujeres posparto
There is no widely used, statistically validated assessment for physical and mental health for the short- to medium-term in a postpartum population. PROMIS-29 has been validated for the assessment of these factors in a generic population, but has not been specifically evaluated for use with postpartum women.
This study is a longitudinal, single center observational cohort study designed to evaluate the reliability of the Patient-Reported Outcomes Measurement Information System (PROMIS)-29 v2.1 survey in a postpartum population. PROMIS-29 is a survey designed to screen for pain, impairments in mood, physical function, and activities of daily living. While this survey has shown utility in other populations, it has yet to be assessed in an obstetric population. The investigators plan to recruit patients who are recently postpartum from vaginal or cesarean delivery to complete virtual surveys at defined time points (0, 2, 6, and 12 weeks after delivery). The investigators will subject survey data to statistical measures of validity and reliability comparing with contemporaneously collected surveys of established metrics for quality of life (WHOQoLBREF) and general (global) state of health (numerical rating score 1-100).
The hypothesis is that the PROMIS-29 v2.1 questionnaire is a statistically valid and reliable means of assessing physical and mental health in a postpartum population.
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Intervención / Tratamiento
Intervención / Tratamiento
Tipo de estudio
Tipo de estudio
Inscripción (Actual)
Inscripción
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Ontario
-
Toronto, Ontario, Canadá, M5G1X5
- Mount Sinai Hospital
-
-
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Patients who deliver vaginally or by scheduled cesarean section at Mount Sinai Hospital.
Descripción
Inclusion Criteria:
- 18 years old and over
- singleton births
- 37 or more weeks gestational age
- multiparous or nulliparous patients
- spontaneous vaginal delivery or scheduled cesarean delivery with labor analgesia or neuraxial anesthesia
- give informed written consent
Exclusion Criteria:
- refusal to take part
- are unable to give or have withdrawn consent
- patients unable to communicate fluently in English
- patients who are less than 18 years old
- patients who had fetal demise or severely morbid fetal conditions such as intubation, cooling, expected surgical correction of congenital anomaly during hospitalization (although NICU admissions will be included)
- patients who were admitted in ICU
- patients who had failed neuraxial analgesia such as replaced epidurals or failed spinal requiring conversion to general anesthesia
- patients who had general anesthesia for cesarean delivery as defined by "GETA", including sedatives and deep sedation if not intubated
- patients who had intrapartum cesarean or had assisted/operative (i.e. vacuum, forceps) vaginal delivery.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Modelos observacionales: COHORT
- Perspectivas temporales: PROSPECTIVE
Número de grupos/cohortes
Cohortes e Intervenciones
Grupo / CohorteGrupo / Cohorte |
Intervención / TratamientoIntervención / Tratamiento |
|---|---|
|
Vaginal delivery
Patients who have vaginal deliveries with neuraxial labour analgesia. |
PROMIS-29 is a survey designed to screen for pain, impairments in mood, physical function, and activities of daily living.
Otros nombres:
The WHOQOL-BREF is a 26-item version of the 100-item WHOQOL-100 quality of life measure that addresses four quality of life domains: physical health, psychological health, social relationships and environment.
Otros nombres:
The EQ-5D-3L1 is a generic measure of health status consisting of two parts. The first part assesses health in five dimensions: MOBILITY, SELFCARE, USUAL ACTIVITIES, PAIN / DISCOMFORT, ANXIETY/DEPRESSION. The second part of the questionnaire consists of a VAS on which the patient rates their perceived health from 0 (the worst imaginable health) to 100 (the best imaginable health).
Otros nombres:
|
|
Cesarean delivery
Patients who have a scheduled cesarean delivery with neuraxial anesthesia. |
PROMIS-29 is a survey designed to screen for pain, impairments in mood, physical function, and activities of daily living.
Otros nombres:
The WHOQOL-BREF is a 26-item version of the 100-item WHOQOL-100 quality of life measure that addresses four quality of life domains: physical health, psychological health, social relationships and environment.
Otros nombres:
The EQ-5D-3L1 is a generic measure of health status consisting of two parts. The first part assesses health in five dimensions: MOBILITY, SELFCARE, USUAL ACTIVITIES, PAIN / DISCOMFORT, ANXIETY/DEPRESSION. The second part of the questionnaire consists of a VAS on which the patient rates their perceived health from 0 (the worst imaginable health) to 100 (the best imaginable health).
Otros nombres:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System) survey score
Periodo de tiempo: 24 hours
|
The PROMIS survey score at 24 hours postpartum |
24 hours
|
|
WHOQoLBREF (World Health Organization Quality of Life Brief Version) survey score
Periodo de tiempo: 24 hours
|
The WHOQoLBREF survey score at 24 hours postpartum |
24 hours
|
|
EQ-5D-3L1 (not an acronym) survey score
Periodo de tiempo: 24 hours
|
The EQ-5D-3L1 survey score at 24 hours postpartum |
24 hours
|
|
PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System) survey score
Periodo de tiempo: 2 weeks
|
The PROMIS survey score at 2 weeks postpartum |
2 weeks
|
|
WHOQoLBREF (World Health Organization Quality of Life Brief Version) survey score
Periodo de tiempo: 2 weeks
|
The WHOQoLBREF survey score at 2 weeks postpartum |
2 weeks
|
|
EQ-5D-3L1 (not an acronym) survey score
Periodo de tiempo: 2 weeks
|
The EQ-5D-3L1 survey score at 2 weeks postpartum |
2 weeks
|
|
PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System) survey score
Periodo de tiempo: 6 weeks
|
The PROMIS survey scores at 6 weeks postpartum |
6 weeks
|
|
WHOQoLBREF (World Health Organization Quality of Life Brief Version) survey score
Periodo de tiempo: 6 weeks
|
The WHOQoLBREF survey score at 6 weeks postpartum |
6 weeks
|
|
EQ-5D-3L1 (not an acronym) survey score
Periodo de tiempo: 6 weeks
|
The EQ-5D-3L1 survey score at 6 weeks postpartum |
6 weeks
|
|
PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System) survey score
Periodo de tiempo: 12 weeks
|
The PROMIS survey score at 12 weeks postpartum |
12 weeks
|
|
WHOQoLBREF (World Health Organization Quality of Life Brief Version) survey score
Periodo de tiempo: 12 weeks
|
The WHOQoLBREF survey score at 12 weeks postpartum |
12 weeks
|
|
EQ-5D-3L1 (not an acronym) survey score
Periodo de tiempo: 12 weeks
|
The EQ-5D-3L1 survey score at 12 weeks postpartum |
12 weeks
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Investigadores
Investigadores
- Investigador principal: Ronald George, MD, MOUNT SINAI HOSPITAL
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Inicio del estudio
Finalización primaria (Actual)
Finalización primaria
Finalización del estudio (Actual)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
Otros números de identificación del estudio
- 23-03
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .